{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:55:42Z","timestamp":1791932142225,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["\/ NIAID AI152501"],"award-info":[{"award-number":["\/ NIAID AI152501"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1 U19 AI117941"],"award-info":[{"award-number":["1 U19 AI117941"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1U19 AI149504"],"award-info":[{"award-number":["1U19 AI149504"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","award":["HPRTsh734"],"award-info":[{"award-number":["HPRTsh734"]}],"id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010296","name":"James B. Pendleton Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016951","name":"UCLA AIDS Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017823","name":"Center for AIDS Research, University of California Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ymthe.2023.12.007","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T22:13:31Z","timestamp":1702332811000},"page":"384-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["In\u00a0vivo selection of anti-HIV-1 gene-modified human hematopoietic stem\/progenitor cells to enhance engraftment and HIV-1 inhibition"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4200-004X","authenticated-orcid":false,"given":"Qi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keval","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Brinkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Zakarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Pernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wannisa","family":"Khamaikawin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Hacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-9470","authenticated-orcid":false,"given":"Dong Sung","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.12.007_bib1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3201\/eid2706.210284","article-title":"Reflections on 40 Years of AIDS","volume":"27","author":"De Cock","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.12.007_bib3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV Epidemic: A Plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2023.12.007_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.12.007_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav2045","article-title":"No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication","volume":"5","author":"Bozzi","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2023.12.007_bib6","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3390\/v13122512","article-title":"Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection","volume":"13","author":"Lau","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2023.12.007_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41586-020-2651-8","article-title":"Distinct viral reservoirs in individuals with spontaneous control of HIV-1","volume":"585","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.12.007_bib8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(20)30264-6","article-title":"Kick and kill for HIV latency","volume":"395","author":"Lewin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2023.12.007_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40121-018-0201-6","article-title":"A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population","volume":"7","author":"Chawla","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ymthe.2023.12.007_bib10","first-page":"891","article-title":"Cost-effectiveness and budget impact of dolutegravir\/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States","volume":"27","author":"Butler","year":"2021","journal-title":"J.\u00a0Manag. Care Spec. Pharm."},{"key":"10.1016\/j.ymthe.2023.12.007_bib11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10461-019-02721-3","article-title":"Crystal Clear with Active Visualization: Understanding Medication Adherence Among Youth Living with HIV","volume":"24","author":"Christodoulou","year":"2020","journal-title":"AIDS Behav."},{"key":"10.1016\/j.ymthe.2023.12.007_bib12","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41598-020-80247-8","article-title":"Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients","volume":"11","author":"Imahashi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2023.12.007_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11481-019-09868-9","article-title":"Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury","volume":"16","author":"Yuan","year":"2021","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.ymthe.2023.12.007_bib14","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41591-021-01503-6","article-title":"Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy","volume":"27","author":"Blazkova","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.12.007_bib15","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5\u039432\/\u039432 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.12.007_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.12.007_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.12.007_bib18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2023.02.030","article-title":"HIV-1 remission and possible cure in a woman after haplo-cord blood transplant","volume":"186","author":"Hsu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.12.007_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","article-title":"In-depth virological and immunological characterization of HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Jensen","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.12.007_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41591-023-02215-9","article-title":"HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation","volume":"29","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.12.007_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V94.1.368.413a47_368_371","article-title":"A Clinical Trial of Retroviral-Mediated Transfer of arev-Responsive Element Decoy Gene Into CD34+Cells From the Bone Marrow of Human Immunodeficiency Virus-1\u2013Infected Children","volume":"94","author":"Kohn","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.12.007_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm.1932","article-title":"Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells","volume":"15","author":"Mitsuyasu","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.12.007_bib23","doi-asserted-by":"crossref","first-page":"36ra43","DOI":"10.1126\/scitranslmed.3000931","article-title":"RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma","volume":"2","author":"DiGiusto","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.12.007_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.omtm.2020.03.004","article-title":"Experimental Treatment of SIV-Infected Macaques via Autograft of CCR5-Disrupted Hematopoietic Stem and Progenitor Cells","volume":"17","author":"Yu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.12.007_bib25","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jcyt.2015.03.486","article-title":"A novel in\u00a0vivo chemoselection strategy for genetically modified hematopoietic stem cells","volume":"17","author":"Hacke","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymthe.2023.12.007_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exphem.2011.09.009","article-title":"Combined preconditioning and in\u00a0vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrow","volume":"40","author":"Hacke","year":"2012","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2023.12.007_bib27","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.transproceed.2013.01.020","article-title":"Genetic modification of mouse bone marrow by lentiviral vector-mediated delivery of hypoxanthine-Guanine phosphoribosyltransferase short hairpin RNA confers chemoprotection against 6-thioguanine cytotoxicity","volume":"45","author":"Hacke","year":"2013","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.ymthe.2023.12.007_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2006.05.015","article-title":"Optimization and Functional Effects of Stable Short Hairpin RNA Expression in Primary Human Lymphocytes via Lentiviral Vectors","volume":"14","author":"An","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.12.007_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059594","article-title":"Knockdown of HPRT for Selection of Genetically Modified Human Hematopoietic Progenitor Cells","volume":"8","author":"Choudhary","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.12.007_bib30","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood.V110.11.2590.2590","article-title":"In\u00a0Vitro and In\u00a0Vivo Selection of Genetically Modified Cells Using shRNA Against HPRT and Treatment with 6-thioguanine","volume":"110","author":"Porter","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.12.007_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-0556-7-8","article-title":"Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5","volume":"7","author":"Shimizu","year":"2009","journal-title":"Genet. Vaccin. Ther."},{"key":"10.1016\/j.ymthe.2023.12.007_bib32","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1038\/mtna.2015.10","article-title":"Engineering Cellular Resistance to HIV-1 Infection In\u00a0Vivo Using a Dual Therapeutic Lentiviral Vector","volume":"4","author":"Burke","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2023.12.007_bib33","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.humimm.2017.10.001","article-title":"Frequencies of gene variant CCR5-\u039432 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers","volume":"78","author":"Solloch","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ymthe.2023.12.007_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/imammb\/dqz011","article-title":"A mathematical model of HIV dynamics treated with a population of gene-edited haematopoietic progenitor cells exhibiting threshold phenomenon","volume":"37","author":"Ratti","year":"2020","journal-title":"Math. Med. Biol."},{"key":"10.1016\/j.ymthe.2023.12.007_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57646","article-title":"Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation","volume":"10","author":"Cardozo-Ojeda","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2023.12.007_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006956","article-title":"Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy","volume":"14","author":"Peterson","year":"2018","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2023.12.007_bib37","series-title":"A Pilot Study to Evaluate the Feasibility, Safety and Engraftment of Zinc Finger Nuclease (ZFN) CCR5 Modified CD34+ Hematopoietic Stem\/Progenitor Cells (SB-728mR-HSPC) in HIV-1 (R5) Infected Patients (clinicaltrials.Gov)","year":"2023"},{"key":"10.1016\/j.ymthe.2023.12.007_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omtm.2017.11.004","article-title":"A Combined In\u00a0Vivo HSC Transduction\/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice","volume":"8","author":"Wang","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.12.007_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/gt.2009.118","article-title":"Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in\u00a0vivo","volume":"17","author":"Kiem","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2023.12.007_bib40","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1172\/JCI40767","article-title":"Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates","volume":"120","author":"Beard","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.12.007_bib41","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1089\/hum.2005.16.1355","article-title":"Hematopoietic stem cell transduction and amplification in large animal models","volume":"16","author":"Trobridge","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2023.12.007_bib42","doi-asserted-by":"crossref","first-page":"133ra57","DOI":"10.1126\/scitranslmed.3003425","article-title":"Extended survival of glioblastoma patients after chemoprotective HSC gene therapy","volume":"4","author":"Adair","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.12.007_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood-2013-01-482224","article-title":"Positive selection of mC46-expressing CD4+ T\u00a0cells and maintenance of virus specific immunity in a primate AIDS model","volume":"122","author":"Younan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.12.007_bib44","first-page":"412","article-title":"Immunological aspects of purine metabolism","volume":"76A","author":"Seegmiller","year":"1977","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2023.12.007_bib45","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1038\/s41598-021-87955-9","article-title":"Induced pluripotent stem cells from subjects with Lesch-Nyhan disease","volume":"11","author":"Sutcliffe","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2023.12.007_bib46","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/stem.3087","article-title":"HPRT and Purine Salvaging Are Critical for Hematopoietic Stem Cell Function","volume":"37","author":"Vogel","year":"2019","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2023.12.007_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1172-2-48","article-title":"Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome","volume":"2","author":"Torres","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2023.12.007_bib48","article-title":"Clinical efficacy and safety of 6-thioguanine in the treatment of childhood acute lymphoblastic leukemia","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymthe.2023.12.007_bib49","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.5045\/br.2020.S002","article-title":"Treatments for children and adolescents with AML","volume":"55","author":"Kim","year":"2020","journal-title":"Blood Res."},{"key":"10.1016\/j.ymthe.2023.12.007_bib50","doi-asserted-by":"crossref","first-page":"608653","DOI":"10.3389\/fimmu.2020.608653","article-title":"Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease","volume":"11","author":"Blanco","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.12.007_bib51","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.omtm.2021.10.003","article-title":"Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones","volume":"23","author":"Uchiyama","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.12.007_bib52","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-Cell Gene Therapy for the Wiskott\u2013Aldrich Syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.12.007_bib53","first-page":"S112","volume":"27","author":"Walters","year":"2021","journal-title":"Transpl. Cell. Ther."},{"key":"10.1016\/j.ymthe.2023.12.007_bib54","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/cells11111843","article-title":"Hematopoietic Stem Cell Gene-Addition\/Editing Therapy in Sickle Cell Disease","volume":"11","author":"Germino-Watnick","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2023.12.007_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053492","article-title":"Engineering HIV-1-Resistant T-Cells from Short-Hairpin RNA-Expressing Hematopoietic Stem\/Progenitor Cells in Humanized BLT Mice","volume":"7","author":"Ringpis","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2023.12.007_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1073\/pnas.232688199","article-title":"Inhibiting HIV-1 infection in human T\u00a0cells by lentiviral-mediated delivery of small interfering RNA against CCR5","volume":"100","author":"Qin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.12.007_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mtm.2013.11","article-title":"Preclinical safety and efficacy of an anti\u2013HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor","volume":"1","author":"Wolstein","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.12.007_bib58","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2009-04-215855","article-title":"A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model","volume":"115","author":"Shimizu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.12.007_bib59","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1038\/mtna.2015.3","article-title":"RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice","volume":"4","author":"Shimizu","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2023.12.007_bib60","article-title":"Robust CAR-T memory formation and function via hematopoietic stem cell delivery","volume":"17","author":"Zhen","year":"2021","journal-title":"Plos Pathog."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162300669X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162300669X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:47:35Z","timestamp":1777618055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162300669X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S152500162300669X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.12.007","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vivo selection of anti-HIV-1 gene-modified human hematopoietic stem\/progenitor cells to enhance engraftment and HIV-1 inhibition","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023","name":"copyright","label":"Copyright"}]}}